Skip to main content
SpringerLink
Log in

Palonosetron in allen CINV-Phasen effektiv

Supportivtherapie

  • infopharm
  • Published:
Info Onkologie Aims and scope

Palonosetron stellt als einziges Setron bei zytostatikainduzierter Übelkeit und Erbrechen (CINV) in der akuten sowie der verzögerten Phase eine effektive Basisprophylaxe dar, wie aktuelle klinische Daten bestätigen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Fachpressegespräch „Palonosetron: Stützpfeiler der Antiemese in der Onkologie“ anlässlich des DKK 2014, Berlin, 21. Februar 2014; Veranstalter: RIEMSER

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Claudia Bruhn

Authors
  1. Claudia Bruhn
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bruhn, C. Palonosetron in allen CINV-Phasen effektiv. Info Onkol. 17, 49 (2014). https://doi.org/10.1007/s15004-014-0826-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-014-0826-x

Search

Navigation